Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
18 studies found for:    Open Studies | "Tick-Borne Diseases"
Show Display Options
Rank Status Study
1 Recruiting A Phase II, Open Label Trial of a Vaccine (FSME-IMMUN 0.5 mL Baxter) Against Tick-borne Encephalitis (TBE) for NIAID Workers Manipulating Tick Borne Encephalitis Virus (TBEV) in the Laboratory
Conditions: Tick-Borne Encephalitis;   Encephalitis, Tick-Borne;   Tick-Borne Disease;   Glycoprotein E, Flavivirus;   NSI Protein, Flavivirus
Intervention: Biological: FSME-IMMUN 0.5ml Baxter
2 Unknown  Human Anaplasmosis in Eastern France
Conditions: Anaplasmosis;   Tick-borne Disease;   Ehrlichia
Intervention: Procedure: Blood sampling
3 Unknown  Postencephalitic Symptoms After Tick Borne Encephalitis
Condition: Central European Encephalitis
Intervention:
4 Recruiting Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever)
Conditions: Visceral Leishmaniasis;   Human African Trypanosomiasis;   Enteric Fever;   Melioidosis;   Brucellosis;   Leptospirosis;   Relapsing Fever;   Rickettsial Diseases;   HIV;   Tuberculosis;   Malaria;   Amoebic Liver Abscess
Interventions: Device: rk28 ICT;   Device: IT LEISH (rK39);   Device: Immunochromatographic HAT test;   Device: HAT Serostrip;   Device: Card Agglutination Trypanosoma Test (CATT)-10;   Device: Typhidot M;   Device: S. typhi IgM/IgG;   Device: Test-it Typhoid IgM;   Device: Test-it Leptospirosis IgM;   Device: Leptospira IgG/IgM
5 Not yet recruiting Study of Lyme Neuroborreliosis
Condition: Lyme Neuroborreliosis
Interventions: Drug: Doxycycline;   Drug: Ceftriaxone
6 Unknown  Doxycycline and Ceftriaxone in Suspected Early Lyme Neuroborreliosis
Condition: Suspected Early Lyme Neuroborreliosis
Interventions: Drug: doxycycline;   Drug: ceftriaxone
7 Recruiting Analysis of Lyme Disease Lesions
Conditions: Erythema Migrans Lesions;   Erythema Migrans
Intervention:
8 Unknown  Humoral Response to Tick-borne Encephalitis Vaccine in Elderly
Condition: Tick-borne Encephalitis
Intervention: Biological: FSME-immune
9 Recruiting Humoral and Cellular Immunity for TBE Vaccination in Allogeneic HSCT Recipients
Condition: Tick Borne Encephalitis
Intervention: Biological: TBE virus vaccine
10 Recruiting Evaluation, Treatment, and Follow-up of Patients With Lyme Disease
Condition: Lyme Disease
Intervention:
11 Recruiting Doxycycline in Therapy of Erythema Migrans
Condition: Lyme Borreliosis
Intervention: Drug: Doxycycline
12 Recruiting Searching for Persistence of Infection in Lyme Disease
Conditions: Lyme Disease;   Borrelia Burgdorferi
Interventions: Procedure: Skin Biopsy;   Device: Xenodiagnosis;   Procedure: Blood Drawing
13 Recruiting Culture Media for Borrelia Burgdorferi Sensu Lato
Condition: Erythema Migrans
Interventions: Other: MKP media;   Other: BSK-H media
14 Recruiting Antibiotic Treatment of Multiple Erythema Migrans
Condition: Multiple Erythema Migrans
Interventions: Drug: ceftriaxone;   Drug: doxycycline;   Other: erythema migrans patients treated with doxycycline
15 Recruiting Evaluation of Lyme Disease: Clinical, Microbiological and Immunological Characteristics
Condition: Lyme Disease
Intervention:
16 Recruiting Cytokines and Chemokines in Erythema Migrans
Condition: Erythema Migrans
Intervention: Drug: antibiotic treatment
17 Unknown  Babesia Testing in Blood Donors
Condition: Transfusion Transmitted Babesiosis
Intervention: Biological: B.microti diagnostic blood tests
18 Recruiting Study on Early Lyme Neuroborreliosis
Condition: Nervous System Lyme Borreliosis
Intervention: Drug: ceftriaxone

Indicates status has not been verified in more than two years